126 related articles for article (PubMed ID: 3136700)
1. [Combined effects of interferon alpha-A/D with fluoropyrimidine derivatives in the subrenal capsule assay].
Nishiyama M; Takagami S; Kirihara Y; Saeki T; Niimi K; Kim R; Jinushi K; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2285-90. PubMed ID: 3136700
[TBL] [Abstract][Full Text] [Related]
2. The antiproliferative effects of fluoropyrimidine derivatives against human tumor xenografts in a subrenal capsule assay.
Nishiyama M; Takagami S; Kirihara Y; Saeki T; Hirabayashi N; Nosoh Y; Niimoto M; Hattori T
Jpn J Surg; 1988 Nov; 18(6):725-8. PubMed ID: 2977626
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity test for 5-fluorouracil and its analogues, 1-(2-tetrahydrofuryl)-5-fluorouracil, uracil/1-(2-tetrahydrofuryl)-5-fluorouracil (4:1) and 1-hexylcarbamoyl-5-fluorouracil, using the subrenal capsule assay.
Anai H; Maehara Y; Kusumoto H; Kusumoto T; Sugimachi K
Oncology; 1988; 45(3):144-7. PubMed ID: 3130595
[TBL] [Abstract][Full Text] [Related]
4. UFT is more antineoplastic against gastric carcinoma than 5-fluorouracil, 1-(2-tetrahydrofuryl)-5-fluorouracil and 1-hexylcarbamoyl-5-fluorouracil.
Maehara Y; Kusumoto T; Kusumoto H; Anai H; Sugimachi K
Chemotherapy; 1988; 34(6):484-9. PubMed ID: 3149571
[TBL] [Abstract][Full Text] [Related]
5. [Results of the UFT sensitivity test using human urogenital cancers transplanted subcutaneously and under the subrenal capsule of nude mice].
Murahashi I; Honda M; Mukae K; Hosoya Y; Takasaki E
Gan To Kagaku Ryoho; 1988 Feb; 15(2):231-5. PubMed ID: 3124766
[TBL] [Abstract][Full Text] [Related]
6. [Assessment of the combined effects of mitomycin C with alpha-interferon or gamma-interferon by the clonogenic assay technique].
Hirabayshi N; Nishiyama M; Yamaguchi M; Yoshinaka K; Nosoh Y; Toge T; Niimoto M; Hattori T; Ohkita T
Gan To Kagaku Ryoho; 1985 May; 12(5):1056-62. PubMed ID: 3922307
[TBL] [Abstract][Full Text] [Related]
7. [Combination chemotherapy of human renal cell carcinoma in athymic nude mice with human lymphoblastoid interferon (HLBI) and UFT, 5-Fu].
Yamada Y; Muramatsu T; Honda N; Fukatsu H; Segawa A; Hirata N; Senda H
Hinyokika Kiyo; 1990 May; 36(5):527-34. PubMed ID: 2119093
[TBL] [Abstract][Full Text] [Related]
8. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
[TBL] [Abstract][Full Text] [Related]
9. [Experimental studies on subrenal capsule assay using cyclosporin A treated mice--the optimal treatment schedules of CsA and anticancer agents (mitomycin C and 5-fluorouracil)].
Kusuyama T; Okuyama Y; Fujita M; Taguchi T
Gan To Kagaku Ryoho; 1990 Feb; 17(2):259-67. PubMed ID: 2105699
[TBL] [Abstract][Full Text] [Related]
10. [Antitumor activity of UFT and interferon-alpha against human renal cell carcinoma in athymic nude mice].
Yanase I; Shirahama T; Kayajima T; Ohi Y
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):709-12. PubMed ID: 3128184
[TBL] [Abstract][Full Text] [Related]
11. [Human colorectal carcinoma is more sensitive to HCFU than 5-FU and tegafur in in vitro and in vivo drug sensitivity tests].
Kusumoto T; Maehara Y; Anai H; Kusumoto H; Miyamoto K; Fukuchi K; Sugimachi K
Gan To Kagaku Ryoho; 1988 Feb; 15(2):257-61. PubMed ID: 3124767
[TBL] [Abstract][Full Text] [Related]
12. Effects of alpha and gamma interferons and cytostatics on ovarian cancer in the subrenal capsule assay.
Grönroos M; Mäenpää J; Söderström KO; Kangas L; Leppänen M; Cantell K
Med Biol; 1983; 61(5):275-9. PubMed ID: 6200736
[TBL] [Abstract][Full Text] [Related]
13. [In vivo chemosensitivity test for UFT and FT-207. I--Subrenal capsule assay].
Nishiyama M; Niimi K; Yamaguchi M; Hirabayashi N; Nosoh Y; Tohge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1987 Jan; 14(1):109-13. PubMed ID: 3099648
[TBL] [Abstract][Full Text] [Related]
14. [Chemosensitivity testing for 5-FU and 5-FU derivatives using subrenal capsule assay].
Anai H; Maehara Y; Kusumoto H; Masuda H; Sugimachi K
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):635-8. PubMed ID: 3103537
[TBL] [Abstract][Full Text] [Related]
15. Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts.
Sakurai Y; Yoshida I; Kamoshida S; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
Ann Surg Oncol; 2008 Aug; 15(8):2301-9. PubMed ID: 18506536
[TBL] [Abstract][Full Text] [Related]
16. [In vivo chemosensitivity test for UFT and FT-207. II. Chemosensitivity test on human tumor xenografts transplanted in nude mice].
Niimi K; Nishiyama M; Hirabayashi N; Yamaguchi M; Nosoh Y; Wang DC; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1281-5. PubMed ID: 3107479
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of the chemotherapeutic effectiveness of UFT, a combination of tegafur [1-(2-tetrahydrofuryl)-5-fluorouracil] with uracil, by oral l-leucovorin.
Okabe H; Toko T; Saito H; Nakano K; Fujioka A; Yuasa C; Takeda S; Unemi N
Anticancer Res; 1997; 17(1A):157-64. PubMed ID: 9066646
[TBL] [Abstract][Full Text] [Related]
18. [Chemosensitivity of head and neck squamous cell carcinomas using subrenal capsule assay--comparative assay of 5-FU, FT, UFT, and HCFU and immunohistochemical study].
Nakashima T; Miyagi M; Kusumoto T
Nihon Jibiinkoka Gakkai Kaiho; 1992 Jan; 95(1):95-103. PubMed ID: 1545316
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M
Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
[TBL] [Abstract][Full Text] [Related]
20. Schedule-dependent synergism of vinorelbine and 5-fluorouracil/UFT against non-small cell lung cancer.
Matsumoto S; Igishi T; Hashimoto K; Kodani M; Shigeoka Y; Nakanishi H; Touge H; Kurai J; Makino H; Takeda K; Yasuda K; Hitsuda Y; Shimizu E
Int J Oncol; 2004 Nov; 25(5):1311-8. PubMed ID: 15492820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
